Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCovestor Ltd
Latest Disclosed Ownership328 shares
Latest Disclosed Value $ 116
Covestor Ltd reports 58.59% decrease in ownership of AMGN / Amgen Inc.

On May 5, 2026 - Covestor Ltd filed a 13F-HR form disclosing ownership of 328 shares of Amgen Inc. (MX:AMGN) valued at $116 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 792 shares of Amgen Inc..

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F AMGEN COMMON 031162100 328 -464 -58.59 0 0.0804
2026-02-06 2025-12-31 13F AMGEN COMMON 031162100 792 178 28.99 0 0.1356
2025-10-30 2025-09-30 13F AMGEN COMMON 031162100 614 130 26.86 0 0.0953
2025-08-11 2025-06-30 13F AMGEN COMMON 031162100 484 14 2.98 0 0.0796
2025-05-12 2025-03-31 13F AMGEN COMMON 031162100 470 41 9.56 0 0.0974
2025-02-13 2024-12-31 13F AMGEN COMMON 031162100 429 -28 -6.13 0 0.0701
2024-11-01 2024-09-30 13F AMGEN COMMON 031162100 457 -653 -58.83 0 0.0928
2024-08-09 2024-06-30 13F AMGEN COMMON 031162100 1,110 333 42.86 0 0.2251
2024-05-10 2024-03-31 13F AMGEN COMMON 031162100 777 -179 -18.72 0 0.1397
2024-02-09 2023-12-31 13F AMGEN COMMON 031162100 956 -99 -9.38 0 0.1873
2023-11-13 2023-09-30 13F AMGEN COMMON 031162100 1,055 335 46.53 0 0.2134
2023-08-11 2023-06-30 13F AMGEN COMMON 031162100 720 87 13.74 0 0.1218
2023-05-15 2023-03-31 13F AMGEN COMMON 031162100 633 -6 -0.94 0 -100.00 0.1333
2023-02-14 2022-12-31 13F/A-1 AMGEN COMMON 031162100 639 -3 -0.47 168 15.86 0.1370
2023-02-14 2022-12-31 13F AMGEN COMMON 031162100 639 -3 168 136.9952
2022-11-14 2022-09-30 13F AMGEN COMMON 031162100 642 -224 -25.87 145 -31.28 0.1278
2022-08-10 2022-06-30 13F AMGEN COM 031162100 866 -20 -2.26 211 -1.40 0.1671
2022-05-13 2022-03-31 13F AMGEN COM 031162100 886 338 61.68 214 73.98 0.1424
2022-02-10 2021-12-31 13F AMGEN COM 031162100 548 548 123 0.1723
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.